N/A N=50 Bariatric Surgery for Morbid Obesity
Obesity · Morbid Obesity
Primary: Size of Adipocytes — 73.4; 99.0; 103.0 µm
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=24 Endoscopic Surgery for Bariatric Revision After Weight Loss Failure
Morbid Obesity · Weight Loss
Primary: Mean Weight Loss — 13.3 Pounds
N/A N=76 Lifestyle Improvement for Teens With Bariatric Surgery
Obesity, Adolescent · Bariatric Surgery Candidate
Primary: Change in Health-related Quality of Life as Measured by the HRQOL-14 — -9 days
N/A N=150 Gastric Procedures for Obesity
Morbid Obesity
Primary: Change in Body Weight — -21.4; -36.6; -7.0 kg
N/A N=72 Randomized Comparison of Laparoscopic Sleeve Gastrectomy and Gastric Bypass for Morbid Obesity
Morbid Obesity · Metabolic Syndrome X · Diabetes Mellitus
Primary: Excess Weight Loss From Baseline — 67.8; 64.2 percentage of EWL
N/A N=11,545 Bariatric Surgery and COVID-19
COVID-19 · Bariatric Surgery Candidate
Primary: Revisions — 746; 316 Participants
Phase 4 N=144 Surgical Conditions During Laparoscopic Bariatric Surgery
Morbid Obesity
Primary: Surgeon Satisfaction Scale — 2.7; 4.1; 3.1; 4.6 Scores on a scale
N/A N=39 Sonographic Evaluation of Visceral Fat After Bariatric Surgery
Morbid Obesity
Primary: Decrease in the Visceral Fat Layer Measured by Ultrasound a Day Before and a Year After Surgery. — 3.6; 7.1; 5.6 visceral fat reduction in centimeters
N/A N=150 Advanced Medical Therapy Versus Advanced Medical Therapy Plus Bariatric Surgery for the Resolution of Type 2 Diabetes
Diabetes Mellitus, Type 2 · Obesity
Primary: Success Rate of Biochemical Resolution of Diabetes at 12 Months as Measured by HbA1c ≤ 6%. — 5; 21; 18 participants — p=0.002
N/A N=50 Pilot Behavioral Support Intervention After Bariatric Surgery
Obesity
Primary: Difference in Mean Health-Related Quality of Life (HRQoL) Scores Related to Physical Function, Energy Level and General Health. — 11.4; 4.6 score on a scale
N/A N=197 Laparoscopic Gastric Bypass vs LAP-BAND for Treatment of Morbid Obesity
Morbid Obesity
Primary: Excess Weight Loss From Pre-operation to 5 Years Post-operation — 68.4; 45.4 percent change
N/A N=30 Development of a Weight Maintenance Intervention for Bariatric Surgery Patients
Obesity, Morbid
Primary: Recruitment Rate — 33 Participants
N/A N=48 An Analysis of Lipid and Glucose Metabolism Following Bariatric Surgery
Morbid Obesity
Primary: Triglycerides Post-prandial — 95; 71; 134 mmol/L
Phase 2 N=12 The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes
Type 2 Diabetes Mellitus · Obesity
Primary: Fasting Glucose — 6.1; 7.23; 6.48; 5.89 mmol/l
N/A N=15 Assessment of Gastric Volume Reduction in Surgical Weight Loss Candidates
Obesity
Primary: Successful Gastric Plication Using Reduction Gastroplasty — 9; 6 participants
N/A N=33 Taste Perception Pre and Post Bariatric Surgery
Morbid Obesity
Primary: Changes on Taste Detection Thresholds After Bariatric Surgery-induced Weight Loss (Roux-en-Y Gastric Bypass and Laparoscopic Adjustable Banding). — 7.5; 8.1; 6.5; 7.5…
N/A N=60 Impact Of Post-Bariatric Body Contouring Procedures on Patient Body Weight and Metabolism
Bariatric Surgery Candidate
Primary: Weight Changes by Kilograms — 94.3; 96.17; 96.27; 89.4 Kilo gram
N/A N=55 Effects of Gastric Bypass Surgery and Calcium Metabolism and the Skeleton
Obesity, Morbid · Gastric Bypass
Primary: Change in Intestinal Calcium Absorption — -25.8 % of ingested calcium that is absorbed
N/A N=88 Surgery or Lifestyle With Intensive Medical Management in the Treatment of Type 2 Diabetes
Type 2 Diabetes Mellitus · Obesity
Primary: Fasting Plasma Glucose <126 mg/dL and HbA1c < 6.5% at Three Years of Follow-up. — 13; 5; 42; 0 % of patients — p=0.60
N/A N=81 Usefulness and Safeness Of Intra-Gastric Balloon Before Bariatric Surgery In Morbid Obesity
Morbid Obesity
Primary: Postsurgical Morbidity on Both Arms of the Study — 10; 8; 8; 4 Participants — p=0.689
N/A N=81 Effects of Different Surgical Methods to Treat Obesity
Obesity · Type 2 Diabetes · Insulin Sensitivity
Primary: Insulin Sensitivity at 2 Years — 6.7; 6.6 glucose/kg body weight/min
Phase 3 N=22 Weight Regain Treatment Post-Bariatric Surgery
Obesity, Overweight
Primary: Body Mass Index — 39.12; 40.48 kg/m2
Phase 2 N=10 Healthy Body, Healthy Bones After Bariatric Surgery Trial
Bariatric Surgery Candidate · Bone Loss · Bone Resorption
Primary: Change in Hip Bone Mineral Density (BMD) — 0; -.03 g/cm2
N/A N=34 Food Preference Following Bariatric Surgery
Obesity
Primary: Total Food Intake (Lunch Buffet) at 24 Months — 2540.1; 721 kJ
N/A N=22 Diabetes and Gastric By- Pass
Type 2 Diabetes
Primary: Response in Glucose AUC at Baseline vs. Following Gastric Bypass Surgery — 61647.0; 59476.1 mg/dL*min
Phase 2 N=46 Study for Short Term Weight Loss in Candidates for Bariatric Surgery
Obesity
Primary: Assessment of % Excess Weight Loss — 45.4 %EWL
N/A N=6 Time Restricted Eating Pilot - Bariatrics
Time Restricted Feeding
Primary: Weight — -.07 kg
N/A N=137 LAGB as a Treatment for Morbid Obesity in Adolescents
Morbid Obesity · Obstructive Sleep Apnea Syndrome · Metabolic Syndrome
Primary: Percentage of Excess Weight Change (EWL) — -35.5 percent change
Phase 4 N=36 Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery
Bariatric Surgery Candidate · Bone Loss
Primary: Percentage Change in Total Hip Bone Mineral Density — 0.60; -6.44 percentage of change
N/A N=20 Endoscopic Suturing for Primary Obesity Treatment
Obesity · Body Weight · Overweight
Primary: Number of Participants With Adverse Events — 5; 2; 0; 13 Participants